XLO
XLO
NASDAQ · Biotechnology

Xilio Therapeutics Inc

$8.32
-0.36 (-4.15%)
As of Mar 29, 10:51 PM ET ·
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +500.2% upside
Low Target $27.43
Average Target $49.94
High Target $65.11
Current Price $8.32
Current
$8.32
Target
$49.94
$27.43 $49.94 avg $65.11
Scenario Analysis
Bear Case
$27.43
229.7%
Low target
Base Case
$49.94
+500.2%
Avg target
Bull Case
$65.11
+682.6%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$16.52
-49.6% from high
52-Week Low
$6.47
+28.6% from low
Target vs 52W High
$49.94
+202.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%